Drug utilisation study of upadacitinib (Rinvoq™) in Europe to evaluate the effectiveness of additional risk minimisation measures

ENCePP Code of conduct

No

Data sources

• Data source(s):
  British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
• Data source(s), other:
  ARTIS Sweden, DANBIO Denmark, BIOBADASER Spain, RABBIT Germany
• Data sources (types):
  Administrative data (e.g. claims)

  Disease registry

  Other
• Data sources (types), other:
  Prospective patient-based data collection

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No